Comparision of the Clinical Efficacy of Different Desensitizing Toothpastes
1 other identifier
interventional
48
1 country
1
Brief Summary
Dentin hypersensitivity is a common problem in society. Untreated hypersensitivity affects the patient's quality of life, complicates plaque control and increases the risk of caries and periodontal disease. This study aimed to evaluate the clinical efficacy of desensitizing toothpastes containing sodium fluoride, stannous fluoride, nano-hydroxyapatite, 8% arginine and calcium carbonate. Fourty eight patients with at least two teeth with positive responses to air and mechanical stimulus were included in the study and were divided into four groups. Sodium fluoride (Colgate®, Cavity Protection) in group A, stannous fluoride (Oral B® Gum Calm \& Sensitivity) in group B, nano-hydroxyapatite (ApaCare®) in group C and 8% arginine and calcium carbonate combination in group D (Colgate® Sensitive Pro- ReliefTM) were used by the patients continuously for 16 weeks. Dentin hypersensitivity, by using VAS and Shiff scores and periodontal parameters were evaluated at baseline, 2nd week, 4th week and last 16th week.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 24, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2023
CompletedFirst Submitted
Initial submission to the registry
December 12, 2023
CompletedFirst Posted
Study publicly available on registry
January 9, 2024
CompletedJanuary 9, 2024
December 1, 2023
8 months
December 12, 2023
December 26, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Hypersensitivity Reduction
Visual Analogue Scale (VAS) measures pain intensity. The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be').
Baseline, 2nd week, 4th week, 16th week
Hypersensitivity Reduction
The Schiff Scale examiner covers the adjacent teeth on either side of the patient's hypersensitive tooth with his/her fingers. Air from the tip of the dental unit's air-water sprayer is applied to the cervical region of the hypersensitive tooth at a distance of approximately 1 cm for 1 second. The degree of hypersensitivity is scored according to the Schiff cold air sensitivity scale. Scoring : Score 0: The individual does not respond to the stimulus. Score 1: The individual responds to the stimulus but does not request its termination. Score 2: The individual responds to the stimulus and requests its termination or moves to avoid the stimulus. Score 3: The individual responds to the stimulus, finds the stimulus painful and requests its termination. The pain persists for a few seconds after the stimulus is terminated.
Baseline, 2nd week, 4th week, 16th week
Secondary Outcomes (4)
Clinical Periodontal Measurements
Baseline, 16th week
Clinical Periodontal Measurements
Baseline, 16th week
Clinical Periodontal Measurements
Baseline, 16th week
Clinical Periodontal Measurements
Baseline, 16th week
Study Arms (4)
Group A (Sodium Monofluorophosphate)
ACTIVE COMPARATORDentifrice containing Sodium Monofluorophosphate, daily homecare usage Colgate®, Cavity Protection
Group B (Stannous Fluoride)
ACTIVE COMPARATORDentifrice containing Stannous Fluoride, daily homecare usage Oral B®, Gum Calm \& Sensitivity
Group C (Nano-Hydroxyapatite)
ACTIVE COMPARATORDentifrice containing Nano-Hydroxyapatite, daily homecare usage ApaCare®
Group D (8% Arginine & Calcium Carbonate)
ACTIVE COMPARATORDentifrice containing 8% Arginine \& Calcium Carbonate, daily homecare usage Colgate®, Sensitive Pro-Relief
Interventions
Test toothpaste, participants will brush selected sensitive teeth each for 30 seconds followed by the whole mouth thoroughly for at least one minute. The method of application of these agents will be the fingertip method. Patients continued to use the paste twice daily, morning and evening, for 16 weeks.
Test toothpaste, participants will brush selected sensitive teeth each for 30 seconds followed by the whole mouth thoroughly for at least one minute. The method of application of these agents will be the fingertip method. Patients continued to use the paste twice daily, morning and evening, for 16 weeks.
Test toothpaste, participants will brush selected sensitive teeth each for 30 seconds followed by the whole mouth thoroughly for at least one minute. The method of application of these agents will be the fingertip method. Patients continued to use the paste twice daily, morning and evening, for 16 weeks.
Test toothpaste, participants will brush selected sensitive teeth each for 30 seconds followed by the whole mouth thoroughly for at least one minute. The method of application of these agents will be the fingertip method. Patients continued to use the paste twice daily, morning and evening, for 16 weeks.
Eligibility Criteria
You may qualify if:
- Dentin hypersensitivity complaints
- Systemically healthy
- Not during pregnancy \& lactation
- No sensitivity treatment in the last 6 months
- Forty-eight patients with positive response to VAS and Schiff tests were included.
You may not qualify if:
- People who have;
- Any systemic disease
- Take regular medication for any other reason
- Undergone periodontal surgery within the last 6 months,
- History of allergy to toothpaste materials,
- Active caries, restoration and/or bridge on the sensitive tooth,
- Orthodontic appliances,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Altinbas University
Istanbul, 34147, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
İlknur ÖZENCİ
Altinbas University
- STUDY DIRECTOR
Şebnem DİRİKAN İPÇİ
Altinbas University
- STUDY DIRECTOR
Gökser ÇAKAR
Altinbas University
- PRINCIPAL INVESTIGATOR
Sevdenur GÜNENÇ
Altinbas University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dentist
Study Record Dates
First Submitted
December 12, 2023
First Posted
January 9, 2024
Study Start
May 1, 2022
Primary Completion
December 24, 2022
Study Completion
February 20, 2023
Last Updated
January 9, 2024
Record last verified: 2023-12